These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships. Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673 [TBL] [Abstract][Full Text] [Related]
3. [Instability of the detrusor muscle. Treatment with oxybutynin chloride (ditropan)]. Perales Cabanas L; Tallada Buñuel M; Romero Maroto J; Escribano Patiño G Actas Urol Esp; 1986; 10(6):481-6. PubMed ID: 3825651 [No Abstract] [Full Text] [Related]
4. Terodiline and oxybutynin in detrusor instability. Drug Ther Bull; 1988 May; 26(10):37-8. PubMed ID: 3383752 [No Abstract] [Full Text] [Related]
5. [Topical treatment with oxybutynin chloride in neurogenic incontinence]. López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234 [TBL] [Abstract][Full Text] [Related]
6. Oxybutynin chloride in the management of idiopathic detrusor instability. Paulson DF South Med J; 1979 Mar; 72(3):374-5. PubMed ID: 424842 [No Abstract] [Full Text] [Related]
7. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome. Schaefer W Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621 [No Abstract] [Full Text] [Related]
8. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder. Goldenberg MM Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730 [TBL] [Abstract][Full Text] [Related]
9. The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled study. Moore KH; Goldstein M; Hay D Br J Obstet Gynaecol; 1990 Nov; 97(11):1063-4. PubMed ID: 2082973 [No Abstract] [Full Text] [Related]
10. Oxybutynin and incontinence during grand mal seizures. Harari D; Malone-Lee JG Br J Urol; 1991 Dec; 68(6):658. PubMed ID: 1773301 [No Abstract] [Full Text] [Related]
11. [Neuropsychiatric adverse effects attributed to use of oxybutynin]. t'Veld BA; Kwee-Zuiderwijk WJ; van Puijenbroek EP; Stricker BH Ned Tijdschr Geneeskd; 1998 Mar; 142(11):590-2. PubMed ID: 9623118 [TBL] [Abstract][Full Text] [Related]
12. Ambulant monitoring to assess the efficacy of oxybutynin chloride in patients with mixed incontinence. van Waalwijk van Doorn ES; Zwiers W Eur Urol; 1990; 18(1):49-51. PubMed ID: 2401307 [TBL] [Abstract][Full Text] [Related]
13. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study. Hooper P; Tincello DG; Richmond DH Br J Urol; 1997 Sep; 80(3):414-6. PubMed ID: 9313659 [TBL] [Abstract][Full Text] [Related]
14. Can oxybutynin cause peripheral neuropathy? Patel HR; Albehussi S; Arya M; Miller RA J Urol; 2002 Aug; 168(2):646. PubMed ID: 12131334 [No Abstract] [Full Text] [Related]
15. The use of Ditropan in the elderly: nursing responsibilities. Anderson CL Perspectives; 1993; 17(3):11. PubMed ID: 8116314 [No Abstract] [Full Text] [Related]
16. Tethered cord syndrome in an adult. Pharmacological treatment of the urological symptomatology by oxybutynin. De Angelis M; Martina G; Caverni L; Coglitore A; Libanori GP; Giannotti P Acta Urol Belg; 1986; 54(1):99-105. PubMed ID: 3962800 [No Abstract] [Full Text] [Related]
17. Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study. Zorzitto ML; Holliday PJ; Jewett MA; Herschorn S; Fernie GR Age Ageing; 1989 May; 18(3):195-200. PubMed ID: 2675580 [TBL] [Abstract][Full Text] [Related]
18. Oxybutynin hydrochloride in the management of detrusor instability. Primus G; Pummer K Int Urol Nephrol; 1990; 22(3):243-8. PubMed ID: 2210980 [TBL] [Abstract][Full Text] [Related]
19. Low dose oxybutynin for the unstable bladder. Malone-Lee J; Lubel D; Szonyi G BMJ; 1992 Apr; 304(6833):1053. PubMed ID: 1586797 [No Abstract] [Full Text] [Related]
20. [Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children]. Aubert D; Cencig P; Royer M Ann Pediatr (Paris); 1986 Sep; 33(7):629-34. PubMed ID: 3777773 [No Abstract] [Full Text] [Related] [Next] [New Search]